Global Eagle Entertainment Inc. (NASDAQ:ENT) and Epizyme, Inc. (NASDAQ:EPZM) See High Volatility in Session

Shares of Global Eagle Entertainment Inc. (NASDAQ:ENT) are showing high volatlity in today’s session as the stock has moved 7.46%, clocking in at $3.17 after a recent bid.

Volatility is the dispersion of returns for a given stock. It is quantified by short-term traders as the average difference between a stock’s daily high and daily low, then divided by the stock price. In other words, volatility refers to the amount of risk about the size of changes in a stock’s value. 

Analyst Views

Based on data provided from analysts polled by Thomson Reuters, Global Eagle Entertainment Inc. has a current consensus target price of 8.83. The current consensus analyst recommendation is sitting at 2.60 on company shares. Investors will likely be tracking any consensus estimate changes heading into the next earnings period.

Moving Averages and ATR

After a recent spot-check, Global Eagle Entertainment Inc. (NASDAQ:ENT)’s ATR is 0.18. The Average True Range (ATR) is a measure of stock volatility. The Average True Range is an exponential moving average (14-days) of the True Range. The range of a day’s trading is high-low, and True Range expands into yesterday’s close when it lands outside of today’s range.

Taking a closer look into the volatility on shares of Global Eagle Entertainment Inc. (NASDAQ:ENT), we notice that the stock is 10.51% off of the 20-Day Simple Moving Average. Zooming out to the 50-Day Simple Moving Average, we can see a difference of 2.53% from current stock levels.

Going out even further, the 200-Day Simple Moving Average is recorded -23.98% away from the current share price. Company shares were recently noted -17.34% off of the 50-day high and 33.19% away from the 50-day low. Let’s also take a quick peek at the 52 week highs/lows. At present, the stock is -67.42% separated from the 52 week high and 33.19% from the low.

Epizyme, Inc. (NASDAQ:EPZM) shares are displaying elevated levels of volatility in today’s session. After a recent check, shares have been spotted at $17.20 showing a change in the session of 7.50%.

Based on data provided from analysts polled by Thomson Reuters, Epizyme, Inc. has a current consensus target price of 23.88. The current consensus analyst recommendation is sitting at 1.60 on company shares. Investors will likely be tracking any consensus estimate changes heading into the next earnings period.

After a recent spot-check, Epizyme, Inc. (NASDAQ:EPZM)’s ATR is 1.03. The Average True Range (ATR) is a measure of stock volatility. The Average True Range is an exponential moving average (14-days) of the True Range. The range of a day’s trading is high-low, and True Range expands into yesterday’s close when it lands outside of today’s range.

Taking a closer look into the volatility on shares of Epizyme, Inc. (NASDAQ:EPZM), we notice that the stock is 3.93% off of the 20-Day Simple Moving Average. Zooming out to the 50-Day Simple Moving Average, we can see a difference of 17.17% from current stock levels.

Going out even further, the 200-Day Simple Moving Average is recorded 22.63% away from the current share price. Company shares were recently noted -8.51% off of the 50-day high and 54.26% away from the 50-day low. Let’s also take a quick peek at the 52 week highs/lows. At present, the stock is -8.51% separated from the 52 week high and 110.78% from the low.

Leave a Comment